Lund-Hansen Torben

CIK 00017531341 companyNEW YORK, NY

Transactions

Companies

Filings

CIK

0001753134

Recent Transactions

13 trades

Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2024-08-28$15.37/sh−50,000→ 35,600 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-08-28−50,000→ 100,000 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2024-08-28$4.38/sh+50,000→ 85,600 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-01-18+35,700→ 35,700 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-01-18+17,800→ 35,600 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-26+32,000→ 32,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-01-17+35,700→ 35,700 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2023-01-17+17,800→ 17,800 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2022-04-26+20,000→ 20,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2021-12-14+32,000→ 32,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2020-12-15+20,000→ 20,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-12-10+20,000→ 20,000 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-12-11+20,000→ 20,000 total

C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR

NEW YORK, NY, 10169